Late HCC onset after direct antiviral agents therapy in patients with sustained virological response: do we need to reconsider their efficacy according to long term follow-up?

Scand J Gastroenterol. 2018 Aug;53(8):1025-1026. doi: 10.1080/00365521.2018.1495260.

Authors

A Perrella¹, A Izzi², R Punzi³, E Adinolfi⁴, C Sbreglia¹, P Bellopede¹, A Galeota Lanza¹, F Martucci¹, L Rinaldi⁴

Affiliations

¹ a VII Department Infectious Disease and Immunology , Ospedali dei Colli P.O. D.Cotugno , Naples , Italy.
² b I Division Infectious Disease , Ospedali dei Colli P.O. D.Cotugno , Naples , Italy.
³ c VI Divisione Infectious Disease , Ospedali dei Colli P.O. D.Cotugno , Naples , Italy.
⁴ d Gastroenterology Unit , Università degli Studi della Campania "Luigi Vanvitelli" , Naples , Italy.

PMID: 30231805
DOI: 10.1080/00365521.2018.1495260

No abstract available

Publication types

Letter

MeSH terms

Aged
Antiviral Agents / therapeutic use*
Carcinoma, Hepatocellular / epidemiology*
Carcinoma, Hepatocellular / etiology
Female
Follow-Up Studies
Hepatitis C, Chronic / complications*
Hepatitis C, Chronic / drug therapy*
Humans
Italy / epidemiology
Liver Neoplasms / epidemiology*
Liver Neoplasms / etiology
Male
Middle Aged
Sustained Virologic Response

Substances

Antiviral Agents